Benjamin Schmid Bioneer A/S Biography Publications Institution JoVE Articles Benjamin Schmid has not added a biography. If you are Benjamin Schmid and would like to personalize this page please email our Author Liaison for assistance. Publications Establishment of a Human Induced Pluripotent Stem Cell Neuronal Model for Identification of Modulators of A53T α-synuclein Levels and Aggregation PloS One. 2021 | Pubmed ID: 34932569 Astrocytic Reactivity Triggered by Defective Autophagy and Metabolic Failure Causes Neurotoxicity in Frontotemporal Dementia Type 3 Stem Cell Reports. Nov, 2021 | Pubmed ID: 34678206 APOE4 Affects Basal and NMDAR-Mediated Protein Synthesis in Neurons by Perturbing Calcium Homeostasis The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Oct, 2021 | Pubmed ID: 34475200 Generation of Two Gene Edited IPSC-lines Carrying a DOX-inducible NGN2 Expression Cassette with and Without GFP in the AAVS1 Locus Stem Cell Research. Apr, 2021 | Pubmed ID: 33610017 Generation of a Set of Isogenic IPSC Lines Carrying All APOE Genetic Variants (Ɛ2/Ɛ3/Ɛ4) and Knock-out for the Study of APOE Biology in Health and Disease Stem Cell Research. Apr, 2021 | Pubmed ID: 33556820 Corrigendum to "Generation of a Set of Isogenic, Gene-edited IPSC Lines Homozygous for All Main APOE Variants and an APOE Knock-out Line" [Stem Cell Res. 34/1873-5061 (2019) 101349-55] Stem Cell Research. Oct, 2020 | Pubmed ID: 32971461 Generation of Two Isogenic IPSC Lines with Either a Heterozygous or a Homozygous E280A Mutation in the PSEN1 Gene Stem Cell Research. Mar, 2019 | Pubmed ID: 30769329 Generation of a Set of Isogenic, Gene-edited IPSC Lines Homozygous for All Main APOE Variants and an APOE Knock-out Line Stem Cell Research. Jan, 2019 | Pubmed ID: 30660866 Generation of Two IPSC Lines with Either a Heterozygous V717I or a Heterozygous KM670/671NL Mutation in the APP Gene Stem Cell Research. Jan, 2019 | Pubmed ID: 30634129 Modeling Neurodegenerative Diseases with Patient-derived Induced Pluripotent Cells: Possibilities and Challenges New Biotechnology. Oct, 2017 | Pubmed ID: 28579476 Patient IPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B Stem Cell Reports. Mar, 2017 | Pubmed ID: 28216144 Generation of an Isogenic, Gene-corrected IPSC Line from a Pre-symptomatic 28-year-old Woman with an R406W Mutation in the Microtubule Associated Protein Tau (MAPT) Gene Stem Cell Research. Nov, 2016 | Pubmed ID: 27934590 Generation of an Isogenic, Gene-corrected IPSC Line from a Symptomatic 59-year-old Female Patient with Frontotemporal Dementia Caused by an R406W Mutation in the Microtubule Associated Protein Tau (MAPT) Gene Stem Cell Research. Nov, 2016 | Pubmed ID: 27934586 Generation of a Gene-corrected Isogenic Control Cell Line from an Alzheimer's Disease Patient IPSC Line Carrying a A79V Mutation in PSEN1 Stem Cell Research. Sep, 2016 | Pubmed ID: 27879212 Induced Pluripotent Stem Cells (iPSCs) Derived from a Symptomatic Carrier of a S305I Mutation in the Microtubule-associated Protein Tau (MAPT)-gene Causing Frontotemporal Dementia Stem Cell Research. Nov, 2016 | Pubmed ID: 27789411 Generation of an Isogenic, Gene-corrected IPSC Line from a Symptomatic 57-year-old Female Patient with Frontotemporal Dementia Caused by a P301L Mutation in the Microtubule Associated Protein Tau (MAPT) Gene Stem Cell Research. Nov, 2016 | Pubmed ID: 27789409 Generation of Induced Pluripotent Stem Cells Derived from a 77-year-old Healthy Woman As Control for Age Related Diseases Stem Cell Research. Nov, 2016 | Pubmed ID: 27789407 Generation of a Gene-corrected Isogenic Control HiPSC Line Derived from a Familial Alzheimer's Disease Patient Carrying a L150P Mutation in Presenilin 1 Stem Cell Research. Nov, 2016 | Pubmed ID: 27789395 Generation of a Human Induced Pluripotent Stem Cell Line Via CRISPR-Cas9 Mediated Integration of a Site-specific Homozygous Mutation in CHMP2B Stem Cell Research. Jul, 2016 | Pubmed ID: 27558614 Generation of a Human Induced Pluripotent Stem Cell Line Via CRISPR-Cas9 Mediated Integration of a Site-specific Heterozygous Mutation in CHMP2B Stem Cell Research. Jul, 2016 | Pubmed ID: 27558613 Generation of an Isogenic, Gene-corrected Control Cell Line of the Spinocerebellar Ataxia Type 2 Patient-derived IPSC Line H266 Stem Cell Research. Jan, 2016 | Pubmed ID: 27345815 Generation of Spinocerebellar Ataxia Type 2 Patient-derived IPSC Line H196 Stem Cell Research. Jan, 2016 | Pubmed ID: 27345814 Generation of an Isogenic, Gene-corrected Control Cell Line of the Spinocerebellar Ataxia Type 2 Patient-derived IPSC Line H271 Stem Cell Research. Jan, 2016 | Pubmed ID: 27345809 Generation of Spinocerebellar Ataxia Type 2 Patient-derived IPSC Line H266 Stem Cell Research. Jan, 2016 | Pubmed ID: 27345805 Generation of an Isogenic, Gene-corrected Control Cell Line of the Spinocerebellar Ataxia Type 2 Patient-derived IPSC Line H196 Stem Cell Research. Jan, 2016 | Pubmed ID: 27345804 Generation of Spinocerebellar Ataxia Type 2 Patient-derived IPSC Line H271 Stem Cell Research. Jan, 2016 | Pubmed ID: 27345803 Generation of Induced Pluripotent Stem Cells (iPSCs) from an Alzheimer's Disease Patient Carrying a L150P Mutation in PSEN-1 Stem Cell Research. Jan, 2016 | Pubmed ID: 27345792 Produktion av humana neurogenin 2-inducerbara neuroner i en tredimensionell suspensionsbioreaktor Jeanette Wihan1, Isabell Karnatz1, Isabelle Sébastien1, Ralf Kettenhofen1, Benjamin Schmid2, Christian Clausen2, Benjamin Fischer1, Rachel Steeg3, Heiko Zimmermann1,4,5,6, Julia C. Neubauer1,4 1Fraunhofer Project Center for Stem Cell Process Engineering, Fraunhofer Institute for Biomedical Engineering IBMT, 2Bioneer A/S, 3Fraunhofer UK Research Ltd, Technology and Innovation Centre, 4Fraunhofer Institute for Biomedical Engineering IBMT, 5Department of Molecular and Cellular Biotechnology, Saarland University, 6Facultad de Ciencias del Mar, Universidad Católica del Norte JoVE 65085 Neuroscience
Produktion av humana neurogenin 2-inducerbara neuroner i en tredimensionell suspensionsbioreaktor Jeanette Wihan1, Isabell Karnatz1, Isabelle Sébastien1, Ralf Kettenhofen1, Benjamin Schmid2, Christian Clausen2, Benjamin Fischer1, Rachel Steeg3, Heiko Zimmermann1,4,5,6, Julia C. Neubauer1,4 1Fraunhofer Project Center for Stem Cell Process Engineering, Fraunhofer Institute for Biomedical Engineering IBMT, 2Bioneer A/S, 3Fraunhofer UK Research Ltd, Technology and Innovation Centre, 4Fraunhofer Institute for Biomedical Engineering IBMT, 5Department of Molecular and Cellular Biotechnology, Saarland University, 6Facultad de Ciencias del Mar, Universidad Católica del Norte JoVE 65085 Neuroscience
